Financials
Income statement
| Fiscal date | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
|---|---|---|---|---|
| Total reported revenue | 8.9B | 9.3B | 8.5B | 8.5B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 2.8B | 2.9B | 2.7B | 2.6B |
| Other operating expenses | — | — | — | — |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 2.6B | 1.7B | 2.2B | 2.4B |
| Tax provision | 540M | 726M | 511M | 451M |
| Net income | 2.0B | 993M | 1.7B | 1.9B |
| Basic EPS | 1.5 | 0.8 | — | 1.4 |
| Diluted EPS | 1.5 | 0.7 | — | 1.4 |
| Basic average shares | 1.2B | 1.2B | — | 1.2B |
| Diluted average shares | 1.2B | 1.3B | — | 1.2B |
| EBITDA | — | — | — | — |
| Net income from continuing op. | 2.0B | 993M | 1.7B | 1.9B |
| Minority interests | -56M | 154M | -47M | -36M |
| Preferred stock dividends | — | — | — | — |